An antibody-drug conjugate and its uses

TW202633686APending Publication Date: 2026-08-16MEDILINK THERAPEUTICS (SUZHOU) CO LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: TW114144333
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2025-09-28
Filing Date: 2025-11-13
Publication Date: 2026-08-16

Application Information

Patent Timeline

28 Sep 2025

Priority

13 Nov 2025

Application

TW114144333

16 Aug 2026

Publication

TW202633686A

IPC: A61K47/68; A61K39/395; A61P35/00

Inventors: 蔡家強; 鄧漢文

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

This invention relates to an antibody-drug conjugate and its use, specifically an antibody-drug conjugate as shown in Formula I and its use in the prevention and / or treatment of diseases related to abnormal cell activity, including but not limited to its use in the prevention and / or treatment of tumor diseases.

Need to check novelty before this filing date? Find Prior Art